PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 3 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results

27 2 2025 16:05:01 提供 Nasdaq GlobeNewswire

Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio

27 2 2025 16:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March

26 2 2025 08:00:01 提供 Nasdaq GlobeNewswire

Pacira to Report 2024 Financial Results on Thursday February 27, 2025

20 2 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 2 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pacira Announces Updates to Board of Directors

30 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments

21 1 2025 08:00:01 提供 Nasdaq GlobeNewswire

Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization

10 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block

07 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

02 1 2025 16:01:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

06 12 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira Awarded New U.S. Patent Covering EXPAREL Composition

03 12 2024 07:30:00 提供 Nasdaq GlobeNewswire

Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

14 11 2024 10:05:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

12 11 2024 08:00:01 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2024 Financial Results

06 11 2024 16:00:00 提供 Nasdaq GlobeNewswire

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

04 11 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024

30 10 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

21 10 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

07 10 2024 08:00:00 提供 Nasdaq GlobeNewswire